Barclays
CELG

Barclays’s Celgene Corp CELG Stock Holding History

Barclays’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-167,500
Closed -$16.6M – 7238
2019
Q3 		$16.6M Sell
167,500
-76,200
-31% -$7.24M 0.01% 990
2019
Q2 		$22.5M Sell
243,700
-834,200
-77% -$79.2M 0.01% 859
2019
Q1 		$102M Buy
1,077,900
+92,000
+9% +$8.05M 0.07% 229
2018
Q4 		$63.2M Buy
985,900
+37,000
+4% +$2.73M 0.05% 301
2018
Q3 		$84.9M Sell
948,900
-761,900
-45% -$67.3M 0.06% 253
2018
Q2 		$136M Buy
1,710,800
+869,800
+103% +$72.2M 0.12% 136
2018
Q1 		$75M Buy
841,000
+169,500
+25% +$16.3M 0.06% 276
2017
Q4 		$70.1M Buy
671,500
+332,400
+98% +$37.5M 0.06% 285
2017
Q3 		$49.4M Buy
339,100
+41,100
+14% +$5.6M 0.05% 298
2017
Q2 		$38.7M Buy
298,000
+44,500
+18% +$5.45M 0.04% 360
2017
Q1 		$31.5M Sell
253,500
-12,700
-5% -$1.52M 0.03% 385
2016
Q4 		$30.8M Sell
266,200
-260,800
-49% -$29M 0.03% 415
2016
Q3 		$55.1M Buy
527,000
+11,000
+2% +$1.19M 0.06% 238
2016
Q2 		$50.9M Buy
516,000
+16,200
+3% +$1.68M 0.07% 249
2016
Q1 		$50M Sell
499,800
-126,700
-20% -$13M 0.08% 219
2015
Q4 		$74.6M Sell
626,500
-23,900
-4% -$2.77M 0.09% 189
2015
Q3 		$70.2M Sell
650,400
-169,700
-21% -$21.1M 0.08% 200
2015
Q2 		$94.3M Buy
820,100
+230,200
+39% +$26.3M 0.11% 156
2015
Q1 		$67.8M Sell
589,900
-523,700
-47% -$62.6M 0.08% 235
2014
Q4 		$124M Buy
1,113,600
+126,700
+13% +$13.4M 0.12% 136
2014
Q3 		$92.8M Sell
986,900
-189,600
-16% -$17.1M 0.09% 171
2014
Q2 		$100M Sell
1,176,500
-49,900
-4% -$3.79M 0.11% 147
2014
Q1 		$85.2M Buy
1,226,400
+805,200
+191% +$63.8M 0.1% 180
2013
Q4 		$35.4M Sell
421,200
-136,800
-25% -$10.8M 0.04% 478
2013
Q3 		$43M Buy
558,000
+107,200
+24% +$7.51M 0.05% 342
2013
Q2 		$26.4M Buy
+450,800
New +$27.1M 0.03% 504

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Barclays's CELG Position: Q4 2019 in Review

Barclays sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,134,829 shares — an estimated $411M sold.

Barclays first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $411M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barclays reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barclays sold 4,134,829 Celgene Corp shares in Q4 2019, an estimated $411M.
  • Barclays first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Barclays's Celgene Corp position peaked at $411M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.